Actavia Life Sciences Inc (RASP)
0.004
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Actavia Life Sciences Total Assets (Quarterly): 0.0486M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0486M |
| December 31, 2023 | 0.0262M |
| September 30, 2023 | 0.0957M |
| June 30, 2023 | 0.0371M |
| March 31, 2023 | 0.0523M |
| December 31, 2022 | 0.0606M |
| September 30, 2022 | 0.0853M |
| June 30, 2022 | 0.0719M |
| March 31, 2022 | 0.0357M |
| December 31, 2021 | 0.0335M |
| September 30, 2021 | 0.0446M |
| June 30, 2021 | 0.0947M |
| March 31, 2021 | 0.0936M |
| December 31, 2020 | 0.0034M |
| September 30, 2020 | 0.0329M |
| June 30, 2020 | 2.223M |
| March 31, 2020 | 4.943M |
| December 31, 2019 | 4.910M |
| September 30, 2019 | 4.946M |
| June 30, 2019 | 4.994M |
| March 31, 2019 | 5.038M |
| Date | Value |
|---|---|
| December 31, 2018 | 5.164M |
| September 30, 2018 | 5.225M |
| June 30, 2018 | 5.166M |
| March 31, 2018 | 5.572M |
| December 31, 2017 | 6.358M |
| June 30, 2017 | 8.295M |
| March 31, 2017 | 9.079M |
| December 31, 2016 | 9.973M |
| September 30, 2016 | 8.737M |
| June 30, 2016 | 0.0003M |
| March 31, 2016 | 0.0005M |
| December 31, 2015 | 0.0005M |
| September 30, 2015 | 0.0021M |
| June 30, 2015 | 0.0004M |
| March 31, 2015 | 0.0021M |
| December 31, 2014 | 0.0012M |
| September 30, 2014 | 0.0038M |
| June 30, 2014 | 0.0067M |
| March 31, 2014 | 0.0212M |
| December 31, 2013 | 0.0253M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0034M
Minimum
Dec 2020
4.946M
Maximum
Sep 2019
0.9388M
Average
0.0606M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.230M |
| Shareholders Equity (Quarterly) | -2.182M |